Andrea Tan
Stock Analyst at Goldman Sachs
(0.39)
# 2619
Out of 5,370 analysts
53
Total ratings
35.71%
Success rate
-8.39%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
INSM Insmed | Maintains: Strong Buy | 100 112 | 101.26 | 10.61% | 10 | Jun 11, 2025 | |
IOVA Iovance Biotherapeut... | Maintains: Buy | 16 8 | 2.1 | 280.95% | 7 | May 12, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Neutral | 46 51 | 41.19 | 23.82% | 4 | May 5, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 39 27 | 6.64 | 306.63% | 6 | Mar 25, 2025 | |
SGMT Sagimet Biosciences | Maintains: Neutral | 23 6 | 7.3 | -17.81% | 5 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 31 | 15.66 | 97.96% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.73 | 173.97% | 3 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Sell | 2 | 3.77 | -46.95% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 17 | n/a | n/a | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 133.18 | 20.14% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 3.16 | 659.49% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 10 4 | 1.23 | 225.2% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 178 375 | 284.98 | 31.59% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 13 | 6.28 | 107.01% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | n/a | n/a | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 2 | May 24, 2022 |